With China's growing dominance in the biopharma R&D sector, a collection of g | A group of over 20 global pharma leaders met with Japan's Prime Minister Sanae Takaichi to address Japan's declining share of biopharma R&D.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
As China-developed assets gain more attention from biopharma dealmakers, some industry watchers want to cur | As China-developed…
Of the 400 million patients worldwide diagnosed with rare diseases, about 250 million of them live in North and Southeast Asia1.…
Takeda's first-in-class orexin treatment won an FDA nod in narcolepsy. Daiichi Sankyo faced investor pushback after admitting to…
With all the fretting from the pharmaceutical industry about competition from China, patent protection losses, price reduction…
In an initiative to increase the efficiency of drug manufacturing in the United States, the FDA has
Astellas CEO explained to Fierce the company's new five-year plan. A Takeda candidate beat Bristol Myers Squibb's Sotyktu in a…
